2019. POSSIBILITIES OF USING RUXOLITINIB TO IMPROVE THE RESULTS OF allo-HSCT (LITERATURE REVIEW). Voprosy onkologii. 65, 3 (Mar. 2019), 330–336. DOI:https://doi.org/10.37469/0507-3758-2019-65-3-330-336.